Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Mycoses and diabetes].

M Skorepová1

  • 1Centrum pro dermatomykózy Kozní kliniky 1. lékarské fakulty UK a VFN, Praha. mykologie.vfn@seznam.cz

Vnitrni Lekarstvi
|June 15, 2006
PubMed
Summary

Diabetic patients face higher risks of fungal skin infections like onychomycosis, which can lead to serious complications. Effective treatment combines systemic terbinafine with local therapies for diabetic foot and nail infections.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Two cases of fungal infection of nails with participation of Cryptendoxyla hypophloia].

Klinicka mikrobiologie a infekcni lekarstvi·2014
Same author

Chronic pyoderma vegetans triggered by Trichophyton mentagrophytes.

Mycoses·2006
Same author

Selectins and monocyte chemotactic peptide as the markers of atherosclerosis activity.

Physiological research·2004
Same author

Case reports. Tinea gladiatorum due to Trichophyton mentagrophytes.

Mycoses·2002
Same author

The role of erythrocytapheresis in secondary erythrocytosis therapy.

Clinical hemorheology and microcirculation·2002
Same author

[Dermatomycoses].

Casopis lekaru ceskych·1999

Area of Science:

  • Dermatology
  • Diabetology
  • Mycology

Context:

  • Diabetic patients exhibit increased susceptibility to skin infections.
  • While overall fungal infection rates are similar to the general population, diabetics experience specific mycoses more frequently, including tinea pedis, onychomycosis, and candidiasis.

Purpose:

  • To highlight the increased prevalence and severity of certain fungal infections in diabetic patients.
  • To emphasize the potential complications arising from overlooked fungal infections, such as bacterial infections and diabetic foot.
  • To outline an effective therapeutic strategy for onychomycosis in diabetics and the elderly.

Summary:

  • Diabetics are prone to specific fungal infections like onychomycosis and candidiasis.
  • Onychomycosis in diabetics can lead to severe outcomes, including digital gangrene, beyond cosmetic concerns.
  • A combination therapy of systemic terbinafine, chemical ablation, and local treatment is recommended for onychomycosis in diabetics and seniors.

Impact:

  • Improved understanding of fungal infection risks in diabetic populations.
  • Enhanced clinical awareness regarding the serious implications of onychomycosis in diabetics.
  • Guidance for optimized treatment protocols to prevent severe complications and improve patient outcomes.

Related Experiment Videos